S&P Biotech SPDR (XBI)

The tech sector has been under pressure, but these seven index funds offer exposure to a range of tech shares and could become the building blocks of a successful growth portfolio.

3 Biotech Stocks to Buy As Things Heat Up for the Sector

By Tyler Craig, Tales of a Technician Feb 18, 2021

Biotech stocks offer a textbook retracement pattern. The risk is low, and the reward is high. Here's how to play it.

The Cusp of an Amazing Technological Revolution

By Louis Navellier, Editor, Growth Investor Dec 15, 2020

We’re again at the cusp of an amazing technological revolution that will carry the stock market to incredible new highs. Make sure to position yourself to take advantage of this huge profit potential.

7 Index Funds To Buy For Diversified Growth in 2021

By Thomas Yeung, CFA, InvestorPlace Markets Analyst Dec 7, 2020

Index funds offer investors the opportunity for diversified growth. With the S&P 500 and Dow Jones up so much in 2020, here are 7 others.

4 Biotech Stocks to Buy for Big Gains in 2020

By Tezcan Gecgil, InvestorPlace Contributor Sep 18, 2020

The novel coronavirus is weighing on the market, but these four biotech stocks can survive. Here's what you need to know to profit now.

3 Biotech Stock ETFs to Buy For Further Upside In 2021

By Nicolas Chahine, InvestorPlace Contributor Aug 17, 2020

Biotech stocks are winners this year, but there's still room to buy in for profit taking. ETFs such as IBB, XBI and XLV will continue to win.

7 Biotech ETFs to Buy Now For Covid-19 And Beyond

By Todd Shriber, InvestorPlace Contributor Aug 4, 2020

Biotech ETFs are popular and delivering for investors, but not all of these funds need the Covid-19 pandemic to soar.

3 Healthcare Stocks to Buy This Year

By Nicolas Chahine, InvestorPlace Contributor Feb 24, 2020

The buyers are in charge of the healthcare stocks this year. And judging from their charts, these stocks and ETFs in particular offer great opportunities.

First-Mover Advantage Will Benefit Amarin Stock More Than You Think

By Ian Cooper Feb 24, 2020

There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.

3 Top Drug Stocks to Own In 2020

By Ian Cooper Jan 3, 2020

Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative treatments for a variety of medical issues.

4 Top Stock Trades for Friday: MU, Biotech, Bitcoin

By Bret Kenwell, InvestorPlace Contributor Sep 26, 2019

Bitcoin, Biotech, Micron and Starbucks were our top stock trades to watch. Here's how the charts are setting up going into Friday.

Hexo Stock Is Down — But Not Out

By Nicolas Chahine, InvestorPlace Contributor Sep 4, 2019

HEXO stock is down 50% since the end of April. But inside this support zone, the bulls can mount a 20% rally if headlines cooperate.

7 Biotech ETFs That Should Remain Healthy

By Todd Shriber, InvestorPlace Contributor Aug 5, 2019

The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.

7 of the Best SPDR ETFs — Besides SPY and GLD

By Todd Shriber, InvestorPlace Contributor Jul 3, 2019

SPDR ETFs span an array of asset classes, including stocks, bond, commodities and real estate, among others. Here are 7 of the best ETFs to buy from SPDR.

Nasdaq Today: iQiyi Surges on Award; Intel, Cisco Struggle

By Bret Kenwell, InvestorPlace Contributor Jun 27, 2019

Memory stocks like Micron and semiconductor stocks like AMD were on the move in the Nasdaq today. Intel and Cisco weren't so lucky though.

S&P Biotech SPDR (XBI)

The 7 Best Market Sectors for Q4

Biotech Stocks Stand to Benefit as Biden Announces Support for Industry

3 Stocks to Sell Now

3 Beaten-Down ETFs to Buy Before They Rebound

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

S&P Biotech SPDR (XBI)

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

XBI Stock Predictions, Articles, and S&P Biotech SPDR News

Subscriber Sign in